1. Home
  2. VCIG vs JAGX Comparison

VCIG vs JAGX Comparison

Compare VCIG & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VCI Global Limited

VCIG

VCI Global Limited

HOLD

Current Price

$0.84

Market Cap

4.0M

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$1.43

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCIG
JAGX
Founded
2013
2013
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.4M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
VCIG
JAGX
Price
$0.84
$1.43
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
1.8M
9.6M
Earning Date
05-08-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.98
N/A
Revenue
$32,903,041.00
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
$0.87
N/A
Revenue Growth
24.77
12.45
52 Week Low
$0.51
$0.64
52 Week High
$978.00
$25.75

Technical Indicators

Market Signals
Indicator
VCIG
JAGX
Relative Strength Index (RSI) 49.53 62.17
Support Level $0.73 $0.64
Resistance Level $1.14 $1.14
Average True Range (ATR) 0.13 0.18
MACD 0.07 0.03
Stochastic Oscillator 53.04 67.88

Price Performance

Historical Comparison
VCIG
JAGX

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: